Effectiveness of Frontal Plane Adaptability in a Novel Foot Prosthesis

NCT ID: NCT06214026

Last Updated: 2024-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-01

Study Completion Date

2027-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

People with lower extremity amputation (LEA) have persistent problems with balance, falls, residual limb pain, functional mobility, cognitive attention during gait, and satisfaction with participation in daily activities, despite using prostheses. The purpose of this randomized clinical trial is to advance understanding of how dynamic foot design features may help people with LEA This study will include people with above-knee amputations, or with bilateral amputations, or with below-knee amputations and lower levels of mobility.

The main study questions/goals are:

1a) To determine if frontal plane adaptation in a foot prosthesis impacts performance, comfort, activities of daily living, and community mobility in the study populations. To answer this question, we will compare a locked and unlocked version of the novel prosthesis.

1b) To determine how the unlocked investigational foot condition compares to the person's usual foot using the outcomes listed above.

2\) To examine the participants' lived experience during community activities. The study will use performance tests, questionnaires, logbooks, and interviews to monitor person-centered outcomes and perceptions of personal functioning during the use of the investigational foot (locked and unlocked) compared to the person's usual foot.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study design is a randomized cross-over clinical trial design (B1 and B2 phases) comparing a carbon fiber foot that includes a functional, unlocked frontal plane adaptable linkage compared to the same foot with the linkage locked to prevent frontal plane motion. With the linkage locked, the foot is comparable to energy storage and return of a carbon fiber foot. The secondary aim for this clinical trial compares the unlocked foot to the participant's usual foot (A1 and A2 phases), representative of the usual standard of care.

The testing will be conducted following an A1-B1-B2-A2 design. The A conditions are focused on the participant's usual prosthetic foot. The B conditions are focused on locked and unlocked frontal plane adaptable linkages with the order randomized. Block randomization, stratified by study site, will be used to determine the order participants receive the locked and unlocked prosthetic. In our recent clinical trial, we developed a simple pin system to prevent the linkage from rotating.

A1 represents Visit 1, where demographic data are entered. As well, baseline questionnaires and performance data are collected. The participant will become familiar with the online data gathering systems. Then, the participant will be fitted with the adaptable foot by a licensed prosthetist. The linkage will be either locked or unlocked depending on the randomization. People with bilateral amputations will receive symmetrical prostheses.

During the \~2-week B1 phase, the participant will perform their normal community activities and contribute usage data, performance ratings, and qualitative data via the online logbook. There is the possibility that the decision may be made to re-fit the participant with a different stiffness of the study foot/feet that will be better suited. If this happens, the at-home use period of participation will be extended for another 2- to 4 weeks. At the end of the B1 phase, participants will complete standardized questionnaires and performance tests at Visit 2. Then, the linkage will be either locked or unlocked depending on the B1 randomization.

The \~2-week B2 phase will allow the participant to continue community activities and complete online logbooks. At the finish of the B2 phase, questionnaires and performance tests will be completed at Visit 3. A semi-structured interview will occur to compare the locked and unlocked versions.

The purpose of the second \~2-week A2 phase is for the participant to reflect on differences between the adaptable foot and the usual foot after having experiences with the adaptable linkage in the unlocked configuration. Questionnaires and an interview will occur at the final participant session, Visit 4.

Questionnaires: The demographic survey, online questionnaires, and activity logbooks will be developed in REDCap and administered either online or on paper, depending on the participant's preferences. Unique URL invitations are sent to participants via email, and reminders are sent if there is a delay in data entry. Data are collected in a database format for analysis.

Demographic questions cover age, gender, date of amputation, number of prosthetic feet, description of the usual foot (feet), walking aids, overall health rating, fall history, occupation (if working), physical activity, comorbidities, amputation etiology, veteran status, employment status, education level, race, and ethnicity.

The Prosthetic Limb Users Survey of Mobility (PLUS-M™) The PLUS-M 12-item questionnaire examines the difficulty of typical everyday mobility activities on a 5-point Likert scale.

Logbooks: Participants will complete daily structured logbooks. Daily logbooks will capture information about prosthetic use (which prosthesis was worn, length of time worn), any falls, residual limb/bodily pain, and provide an opportunity to make notes about any activities that were noticeably impacted by the prosthetic foot. There will be opportunities for participants to provide information about challenging situations and social interaction using scales and open-ended questions. Participants will be encouraged to provide descriptions of activities, including strengths and limitations of foot performance, and to address ADL that might be associated with secondary conditions such as pain, poor balance, safety, fear of falling, attention to foot placement, bilateral activities, surfaces, and uneven ground. Logbooks will be developed in REDCap and can be completed online or on paper. Logbook data will inform the content of the interviews.

Semi-structured Interviews: There will be interviews after research phases B2 (innovative foot) and A2 (usual foot). These interviews will clarify significant events documented in the logbooks. The focus of interviews will be on gathering information about the participants' experience using different prosthetic feet, with an emphasis on identifying activities that are facilitated or hindered by the functioning of the prosthetic foot. Interviews will be audio recorded for transcription and analysis.

Physical performance tests Forward walking (10-meter walk test) Forward walking at a self-selected speed is a basic test of mobility and is correlated to community function. Spatiotemporal variables during this test will be measured using an instrumented Zeno Walkway.

The Timed Up and Go Test (TUG) For the TUG, the participant, starts sitting in a chair and, on the command "go," rises, walks 3 meters, turns 180 degrees, returns to the chair, and sits down. There is typically one practice and one test. This is a timed test. In addition to total time, spatiotemporal variables during the TUG will be collected using an instrumented Zeno Walkway.

The Three Times Figure of Eight Walk Test (3XF8W) The 3XF8W involves significant turning requirements for the participant. The test was developed to represent walking skills used in everyday life, involving straight and curved paths in both right and left directions. Subjects will begin the task standing between the 2 cones 1.52 m apart. The subject will walk a figure 8 course 3 times for each condition at their self-selected pace and stop when they return to the start position. The outcomes of the test are the time to complete the course and the number of steps taken.

Four-square step test (FSST) The FSST is a complex stepping sequence. The participant is instructed to "Try to complete the sequence as fast as possible without touching the sticks. Both feet must contact the floor in each square. If possible, face forward during the entire sequence." The performance tests are ordered in increasing complexity and challenge for people with lower levels of mobility. The FSST combines side-step in both directions, as well as forward and backward stepping. Spatiotemporal variables during this test will also be collected on an instrumented Zeno Walkway.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

A1, B1, B2, A2 crossover design
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Locked ankle articulation

The design is a randomized cross-over clinical trial following an A1-B1-B2-A2 design. In the locked condition, the 20 degree of frontal plane ankle motion is eliminated by a physical lock. The A conditions will be with the usual foot. The B conditions are randomized to the locked and unlocked investigational foot.

Group Type EXPERIMENTAL

META-Arc foot locked

Intervention Type DEVICE

Participants are provided with the META-Arc from WIllowWood Global, and a locking mechanism prevents side-to-side motion.

Unlocked ankle articulation

The design is a randomized cross-over clinical trial following an A1-B1-B2-A2 design. In the unlocked condition, the 20 degree of frontal plane ankle motion is enabled. The A conditions will be with the usual foot. The B conditions are randomized to the locked and unlocked investigational foot.

Group Type EXPERIMENTAL

META-Arc foot unlocked

Intervention Type DEVICE

Participants are provided with the META-Arc from WIllowWood Global allowing side-to-side motion.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

META-Arc foot locked

Participants are provided with the META-Arc from WIllowWood Global, and a locking mechanism prevents side-to-side motion.

Intervention Type DEVICE

META-Arc foot unlocked

Participants are provided with the META-Arc from WIllowWood Global allowing side-to-side motion.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants will be 16-years or older, regardless of gender, race, or ethnicity.
* Potential participants should reside in the community or an independent living environment.
* The upper weight limit is 165.6 kg (365 lbs.).
* Prosthetic foot sizes 22 cm (approximate US Men's shoe size 5) up to 30 cm (13 US Men's).
* Ability to walk more than 400 m on level ground without an increase in pain.
* At least one year post-amputation and using a prosthesis
* People must have the ability to read, write, and comprehend English.

Exclusion Criteria

* Participants must not have conditions such as skin wounds that preclude the use of a prosthesis.
* People will be excluded if they have fluctuating conditions that may significantly alter gait mechanics during the \~10-week study. Examples include Parkinson's disease, alcoholism, brain tumor, and hereditary cerebellar ataxias.
* Participants may use a walking aid but should not primarily rely on wheelchair mobility.
* People will be discontinued from the study if they become unable to use a prosthesis. Examples include major surgery and trauma. However, because of the potential for fluctuations in prosthesis use with this population, short-term issues will not disqualify people from continued participation when they resume prosthetic use.
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Department of Defense

FED

Sponsor Role collaborator

University of Washington

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Murray Maitland

Professor-Associate: Department of Rehabilitation Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Murray Maitland, PT, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of South Florida

Tampa, Florida, United States

Site Status RECRUITING

WillowWood Global

Mount Sterling, Ohio, United States

Site Status RECRUITING

University of Washington

Seattle, Washington, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Monica Smersh

Role: CONTACT

206-543-6995

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stephanie Carey, PhD

Role: primary

813-974-5765

Alex Arbury, CPO

Role: primary

740-869-3377 ext. 213

Jim Colvin

Role: backup

740-869-3377 ext. 131

Monica Smersh

Role: primary

425-331-9737

Murray Maitland, PhD

Role: backup

4252865278

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OP220033

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

STUDY00017239

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transfemoral Powered Foot and Physical Therapy Study
NCT03625921 ACTIVE_NOT_RECRUITING NA